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A B S T R A C T
Background: Stenting may be a compelling approach to dilating curved lesions in congenital heart
diseases. However, balloon-expandable stents, which are commonly used for congenital heart diseases,
are usually deployed in a straight orientation. In this study, we evaluated the effect of stenting with a
novel curved balloon considered to provide better conformability to the curved-angled lesion.
Materials and methods: In vitro experiments: A Palmaz Genesis1 stent (Johnson & Johnson, Cordis Co,
Bridgewater, NJ, USA) mounted on the Goku1 curve (Tokai Medical Co. Nagoya, Japan) was dilated in
vitro to observe directly the behavior of the stent and balloon assembly during expansion. Animal
experiment: A short Express1 Vascular SD (Boston Scientiﬁc Co, Marlborough, MA, USA) stent and a long
Express1 Vascular LD stent (Boston Scientiﬁc) mounted on the curved balloon were deployed in the
curved vessel of a pig to observe the effect of stenting in vivo.
Results: In vitro experiments: Although the stent was dilated in a curved fashion, stent and balloon
assembly also rotated conjointly during expansion of its curved portion.
Animal experiment: In the primary stenting of the short stent, the stent was dilated with rotation of the
curved portion. The excised stent conformed to the curved vessel. As the long stent could not be
negotiated across the mid-portion with the balloon in expansion when it started curving, the mid-
portion of the stent failed to expand fully. Furthermore, the balloon, which became entangled with the
stent strut, could not be retrieved even after complete deﬂation.
Conclusion: This novel curved balloon catheter might be used for implantation of the short stent in a
curved lesion; however, it should not be used for primary stenting of the long stent. Post-dilation to
conform the stent to the angled vessel would be safer than primary stenting irrespective of stent length.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Obstruction occasionally develops at the angled portion of the
vascular pathway in congenital heart diseases, such as systemic-
pulmonary shunts, the pulmonary artery bifurcation, and right
ventricle to pulmonary artery connections. Stenting may be an
attractive option for treating such a lesion, however, balloon-
expandable stents, which are commonly used for congenital
heart diseases, are usually deployed in a straight orientation.* Corresponding author at: Cardiovascular Center, Showa University Northern
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implanted in a curved lesion. In vitro and in an animal experiment,
we evaluated the feasibility of stenting with a novel curved balloon
for better conformability to angled lesions.
Materials and methods
The Goku1 curve (Tokai Medical Co., Nagoya, Japan) is
manufactured from a relatively compliant polyamide elastomer.
The balloon diameter range is 3, 4, 5, and 6 mm, while each has a
length of 2 cm and 4 cm. The nominal/rated burst pressure is 13/18
atmosphere for all sizes. This balloon catheter is low proﬁle, and
can go through a 4F sheath and its wire lumen accepts a 0.018 in.
guide-wire. A special property of the balloon is that it develops
curvature with some rotation when it is inﬂated (Fig. 1). The curved reserved.
Fig. 1. Serial picture during expansion of the curved balloon. The balloon rotates during curving (a to e).
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respectively. With this property, the curved balloons generate a
uniform stress on the entire length of the vessel wall [1]. In this
preliminary experiment, we performed the following in vitro and
in animal studies. Our aim was to evaluate if primary stenting of
curved lesions would be possible using this balloon.
In vitro experiment
A Palmaz Genesis1 stent (Johnson & Johnson, Cordis Co,
Bridgewater, NJ, USA), which is commonly used for congenital
heart diseases, length 18 mm and dilatable diameter 6 mm was
mounted on this balloon for direct observation of the behavior of
the stent and balloon assembly when it was dilated in vitro.
Animal experiment
The experiment was performed at the Intervention Technical
Center (IVTeC) Kobe laboratory of Medical Device Development
Center (MEDDEC), and the protocol was approved by the local ethical
committee of the MEDDEC. A pig weighing 35 kg was anesthetized
with thiamylal sodium and midazolam and maintained with
sevoﬂurane. We exposed the femoral arteries bilaterally and a
10 F sheath was introduced into each artery.
After selective angiography of the anterior mesenteric artery,
an Express1Vascular SD stent (Boston Scientiﬁc Co, Marlborough,
MA, USA) with a length of 18 mm and a dilatable diameter of
6 mm (short stent) mounted on the Goku1 curve with a diameter
of 6 mm and a length of 40 mm was introduced into the curved
lesion over the guide-wire and dilated. Secondly, an Express1
Vascular LD stent with a length of 37 mm (long stent) and
a dilatable diameter 7 mm mounted on a balloon of the
same speciﬁcation was similarly deployed in the other curved
lesion. Finally, an Express1 Vascular LD stent length 37 mm and
dilatable diameter 7 mm, which was deployed in advance, in
the curved lesion using the straight balloon (TMP Sphere1
6 mm/40 mm, Tokai Medical, Co) was post-dilated by the Goku1
curve (6 mm/40 mm).The animals were killed with intravenous pentobarbital sodium
and potassium chloride and the stented vessels were surgically
removed. We examined the stented vessel macroscopically,
although microscopic examination was not performed.
Results
In vitro experiment
The balloon rotated when its curved portion of Goku1 curve
was expanded. Although the stent was dilated in a curved fashion,
stent and balloon assembly also rotated in unison during
expansion of its curved portion (Fig. 2). Stent integrity was
preserved after dilation with the curved balloon.
Animal experiment
In primary stenting of the short stent, the stent was dilated
with rotation at the curved portion. The excised stent conformed
to the curved vessel (Fig. 3). Meanwhile, as the long stent could not
be negotiated across the mid-portion of the expanded balloon
when it started curving, the mid-portion of the stent failed to
expand fully. Furthermore, the balloon could not be retrieved even
after complete deﬂation. The excised balloon entangled with the
strut at the mid-portion of the stent (Fig. 4). Post-dilation by the
curved balloon bent the stent pre-implanted by the straight
balloon in the curved lesion conforming to the curved vessel
(Fig. 5).
Discussion
Systemic-pulmonary shunts and cavopulmonary connections
are common palliative operations for patients with complicated
congenital heart diseases featuring decreased pulmonary blood
ﬂow. Obstruction at the anastomosis can sometimes develop post-
operatively, which requires urgent surgical or catheter interven-
tion to maintain adequate pulmonary blood ﬂow [2,3]. Successful
Fig. 2. In vitro dilatation of the stent with the curved balloon. The balloon and the stent assembly rotate during expansion of the stent (a to g).
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reported [4–10]. However, acute angulation at the proximal and/or
distal anastomosis may cause slipping of a straight balloon or
excessive stress on the vessel wall adjacent to the stenosis during
the procedure. Previously, we reported efﬁcacy of this novel curved
balloon in transcatheter dilation of the angled lesions associated
with congenital heart diseases [1]. Stenting for curved lesions
is occasionally necessary for an early post-operative, kinked,
compressed, or long-segmented lesion, where simple balloon
dilation has limited efﬁcacy. As we have reported previously, there
may be a risk of damage to the angled vessel by excessive stress at
the mid-portion and at both ends of the greater curvature when itFig. 3. Implantation of the short stent with the curved ballois dilated by a straight balloon [1]. Consequently, we examined the
possibility of stenting with a curved balloon for the angled lesions
in vitro and in an animal model.
In the in vitro study, an 18-mm length Genesis1 stent could be
dilated in a curved fashion, although it rotated during expansion.
As we believe that such rotation may injure the vascular wall by
the edge of the stent, we conducted an animal experiment. Because
of non-availability of the Genesis1 stent, we used short and long
Express1 Vascular stents in the animal experiment. Despite the
different strut patterns in the Genesis1 and Express1 Vascular
stent, the short Express1 Vascular SD stent was successfully
deployed in the curved lesion with similar rotation to that whichon (a to e), and the excised vessel and the stent (f, g).
Fig. 4. Implantation of the long stent with the curved balloon (a to c), and the excised vessel and the stent (d, e).
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any serious injury to the vascular wall such as dissection or
rupture. However, the long stent could not be fully expanded as the
balloon became entangled at the mid-portion of the stent.
Furthermore, the balloon could not be retrieved in this animal.
Because of the folding technique to make the curve, this balloon
spontaneously rotates during inﬂation. We suppose the balloon
with stent on could not be fully dilated without rotation, and
subsequently entangled with the stent at the mid-portion. In post-
dilation of the pre-implanted straight stent, this curved balloon re-
shaped the stent to conform to the curved lesion. We believe, even
though the short stent may be primarily implanted with this
balloon, there is potentially some risk of injury to the vessel wall
with the rotation of the balloon and the stent assembly during
expansion.Fig. 5. The previously implanted straight stent (a) was cHow the long stent can be primarily implanted with this curved
balloon is another concern. We believe that not only stent length
but also some factors such as the balloon diameter, the reference
vessel, and the minimal lumen diameter may determine possibility
of primary stenting with this curved balloon. Considering injury to
the vascular wall with rotation, and that post-dilation with this
balloon could re-shape the pre-implanted straight stent to
conform to the curve, for now, this balloon should be used for
post-dilation problems to conform to the angled lesion rather than
for primary stenting irrespective of the stent length.
Limitations
How much the stent can be curved depends not only on the
property of the curved balloon but also on the mechanical propertyurved by post-dilation by the curved balloon (b, c).
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be deployed in the curved fashion, there are no data on its radial
strength and durability when bent. In this preliminary experiment,
we did not examine such mechanical properties. We examined the
stented vessel only macroscopically, while there are no data on
microscopic changes that may determine long-term prognosis.
Conclusion
This novel curved balloon catheter is a reasonable choice for
better conformability in acutely curved lesions. It might be used for
implantation of the short stent in the curved lesion; however it
should not be used for primary stenting with the long stent. Post-
dilation to conform to the angle would be safer than primary
stenting irrespective of stent length. Further investigation of the
mechanical properties and long-term prognosis of the bent stent
are mandatory.
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